Medicine recalls
|
| |
| The United Kingdom: Class 2 Medicines Recall: hameln pharma ltd, Amiodarone Hydrochloride 50 mg/ml Concentrate for Solution for Injection/Infusion |
| |
Medicines and Healthcare products Regulatory Agency (MHRA) announces that hameln pharma ltd is initiating a recall of batch 207506 of Amiodarone Hydrochloride 50 mg/ml Concentrate for Solution for Injection/Infusion as a precautionary measure. This is due to an increased presence of visible crystalline particles within the solution, identified during ongoing re-inspection of retained samples.
Please refer to the following website in MHRA for details:
http://www.gov.uk/drug-device-alerts/class-2-medicines-recall-hameln-pharma-ltd-amiodarone-hydrochloride-50-mg-slash-ml-concentrate-for-solution-for-injection-slash-infusion-el-22-a-slash-31
In Hong Kong, Amiodarone-hameln Concentrate For Solution For Injection/Infusion 150mg/3ml (HK-65675) is a pharmaceutical product registered by Mekim Ltd. The product is a prescription-only medicine. As confirmed by Mekim Ltd, the affected batch has not been imported into Hong Kong.
Ends/Wednesday, Jul 20, 2022
Issued at HKT 14:00
|
| |
|
